Summary

for people ages 18-75 (full criteria)
at UCLA
study started
estimated completion

Description

Summary

This study will evaluate the efficacy and safety of BOTOX® intravesical instillation in participants with overactive bladder and urinary incontinence.

Official Title

A Phase 2, Multicenter, Randomized, Double-blind, Placebo-controlled, Single-treatment, 2-stage, Dose-finding Study Evaluating the Efficacy and Safety of BOTOX® Intravesical Instillation in Participants With Overactive Bladder and Urinary Incontinence

Keywords

Urinary Incontinence Overactive Bladder With Urinary Incontinence Enuresis Urinary Bladder, Overactive Botulinum Toxins, Type A abobotulinumtoxinA OnabotulinumtoxinA and Hydrogel admixture

Eligibility

You can join if…

Open to people ages 18-75

  • Symptoms of OAB (frequency/urgency) with urinary incontinence for at least 6 months
  • Inadequate response or limiting side effects with pharmacotherapy for the treatment of OAB

You CAN'T join if...

  • Overactive Bladder caused by neurological condition
  • Patient has predominance of stress incontinence
  • History or evidence of pelvic or urological abnormality
  • Prior use of BOTOX for any urological condition

Locations

  • University of California, Los Angeles not yet accepting patients
    Los Angeles California 90024 United States
  • Tower Urology withdrawn
    West Los Angeles California 90048 United States
  • Wr-McCr, Llc not yet accepting patients
    San Diego California 92108 United States

Details

Status
accepting new patients
Start Date
Completion Date
(estimated)
Sponsor
Allergan
Links
Additional information on study locations near you may be found at AllerganClinicalTrials.com. For any study not on AllerganClinicalTrials.com, please contact IR‐CTRegistration@Allergan.com for assistance.
ID
NCT03320850
Phase
Phase 2
Study Type
Interventional
Last Updated